Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * | KEGG DRUG * | DrugBank | 指定難病告示番号 * |
1 | Adherens junction |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
2 | Alcoholism |
2件: DRD1, DRD2 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
1件: DRD2 | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
D00784 | Ropinirole | 3件: 6, 74, 309 | |||
D08489 | |||||
3 | Amphetamine addiction |
1件: DRD1 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
4 | Bladder cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
5 | Breast cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
2件: ESR1, ESR2 | D00962 | Clomifene | 1件: 74 | ||
D07726 | |||||
6 | Calcium signaling pathway |
2件: DRD1, DRD5 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 | ||
D08108 | |||||
7 | cAMP signaling pathway |
3件: DRD1, DRD2, DRD5 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
1件: DRD2 | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
D00784 | Ropinirole | 3件: 6, 74, 309 | |||
D08489 | |||||
3件: SSTR1, SSTR2, SSTR5 | D10147 | Pasireotide | 3件: 67, 74, 75 | ||
8 | Central carbon metabolism in cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
9 | Choline metabolism in cancer |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
10 | Cocaine addiction |
2件: DRD1, DRD2 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
1件: DRD2 | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
D00784 | Ropinirole | 3件: 6, 74, 309 | |||
D08489 | |||||
11 | Colorectal cancer |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
12 | Cushing syndrome |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
13 | Cytokine-cytokine receptor interaction |
1件: GHR | D02691 | Somatotropin | 18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
1件: PRL | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
14 | Dopaminergic synapse |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
1件: DRD2 | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
3件: DRD2, DRD3, DRD4 | D00784 | Ropinirole | 3件: 6, 74, 309 | ||
D08489 | |||||
15 | EGFR tyrosine kinase inhibitor resistance |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
16 | Endocrine and other factor-regulated calcium reabsorption |
1件: ESR1 | D00962 | Clomifene | 1件: 74 |
D07726 | |||||
17 | Endocrine resistance |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
2件: ESR1, ESR2 | D00962 | Clomifene | 1件: 74 | ||
D07726 | |||||
18 | Endocytosis |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
19 | Endometrial cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
20 | Epithelial cell signaling in Helicobacter pylori infection |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
21 | ErbB signaling pathway |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
22 | Estrogen signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
2件: ESR1, ESR2 | D00962 | Clomifene | 1件: 74 | ||
D07726 | |||||
23 | Focal adhesion |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
24 | FoxO signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
25 | Gap junction |
2件: DRD1, DRD2 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
1件: DRD2 | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
D00784 | Ropinirole | 3件: 6, 74, 309 | |||
D08489 | |||||
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 | ||
D08108 | |||||
26 | Gastric acid secretion |
1件: SSTR2 | D10147 | Pasireotide | 3件: 67, 74, 75 |
27 | Gastric cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
28 | Glioma |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
29 | GnRH secretion |
1件: ESR2 | D00962 | Clomifene | 1件: 74 |
D07726 | |||||
30 | GnRH signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
31 | Growth hormone synthesis, secretion and action |
1件: GHR | D02691 | Somatotropin | 18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 |
4件: SSTR1, SSTR2, SSTR3, SSTR5 | D10147 | Pasireotide | 3件: 67, 74, 75 | ||
32 | Hepatitis C |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
33 | Hepatocellular carcinoma |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
34 | HIF-1 signaling pathway |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
35 | Human cytomegalovirus infection |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
36 | Human papillomavirus infection |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
37 | JAK-STAT signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
1件: GHR | D02691 | Somatotropin | 18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 | ||
1件: PRL | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
38 | MAPK signaling pathway |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
39 | Melanoma |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
40 | MicroRNAs in cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
41 | Morphine addiction |
1件: DRD1 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
42 | Neuroactive ligand-receptor interaction |
5件: DRD1, DRD2, DRD3, DRD4, DRD5 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
3件: DRD2, DRD3, DRD4 | D00784 | Ropinirole | 3件: 6, 74, 309 | ||
D08489 | |||||
2件: DRD2, PRL | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
1件: GHR | D02691 | Somatotropin | 18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 | ||
1件: NR3C1 | D00292 | Dexamethasone | 20件: 13, 16, 28, 35, 46, 53, 63, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 222, 296, 299 | ||
D00975 | |||||
D01510 | |||||
D01615 | |||||
D01632 | |||||
D01948 | |||||
D02174 | |||||
D02591 | |||||
D02592 | |||||
4件: SSTR1, SSTR2, SSTR3, SSTR5 | D10147 | Pasireotide | 3件: 67, 74, 75 | ||
43 | Non-small cell lung cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
44 | Oxytocin signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
45 | Pancreatic cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
46 | Parathyroid hormone synthesis, secretion and action |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
47 | Parkinson disease |
2件: DRD1, DRD2 | D00633 | Dopamine | 3件: 6, 7, 74 |
D07870 | |||||
1件: DRD2 | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
D00784 | Ropinirole | 3件: 6, 74, 309 | |||
D08489 | |||||
48 | Pathways in cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
2件: ESR1, ESR2 | D00962 | Clomifene | 1件: 74 | ||
D07726 | |||||
49 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
50 | Phospholipase D signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
51 | PI3K-Akt signaling pathway |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
1件: GHR | D02691 | Somatotropin | 18件: 2, 3, 13, 19, 46, 74, 75, 78, 96, 113, 191, 193, 195, 236, 265, 274, 276, 299 | ||
1件: PRL | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
52 | Platinum drug resistance |
1件: ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
53 | Prolactin signaling pathway |
2件: ESR1, ESR2 | D00962 | Clomifene | 1件: 74 |
D07726 | |||||
1件: PRL | D00780 | Bromocriptine | 2件: 6, 74 | ||
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
54 | Prostate cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
55 | Proteoglycans in cancer |
2件: EGFR, ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
1件: ESR1 | D00962 | Clomifene | 1件: 74 | ||
D07726 | |||||
56 | Rap1 signaling pathway |
1件: DRD2 | D00780 | Bromocriptine | 2件: 6, 74 |
D03165 | |||||
D00987 | Cabergoline | 3件: 6, 74, 75 | |||
D00633 | Dopamine | 3件: 6, 7, 74 | |||
D07870 | |||||
D00784 | Ropinirole | 3件: 6, 74, 309 | |||
D08489 | |||||
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 | ||
D08108 | |||||
57 | Ras signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
58 | Regulation of actin cytoskeleton |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
59 | Relaxin signaling pathway |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
60 | Shigellosis |
1件: EGFR | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 | |||||
61 | Thyroid hormone signaling pathway |
1件: ESR1 | D00962 | Clomifene | 1件: 74 |
D07726 | |||||
62 | Tight junction |
1件: ERBB2 | D04024 | Lapatinib | 3件: 34, 74, 75 |
D08108 |